About Aqua Pharm
Aqua Pharm is a Healthcare company based in West Chester (United States) founded in 2004, and was acquired by Almirall in December 2013. Specialty pharmaceuticals for dermatological conditions are marketed by Aqua Pharm. Aqua Pharm has raised $53.67 million across 1 funding round from investors including Almirall and RoundTable Healthcare Partners. The company has 100 employees. Its chief executive, as recorded, is Ron Menezes. Its focus areas include Life Sciences, Dermatology, Drugs and Aesthetics. Its legal entity is Aqua Pharmaceuticals, LLC. Its competitors include Revance Therapeutics, Dermavant and Sol-Gel Technologies; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2004, Aqua Pharm operates from West Chester, United States, as a provider in the pharmaceutical sector focused on dermatological treatments. Drugs are marketed for conditions including impetigo, acne vulgaris, actinic keratoses, seborrheic dermatitis, atopic dermatitis, and corticosteroid-responsive dermatoses. Key products encompass Altabax, Veltin, Acticlate, Fluoroplex, Xologel, Verdeso, Monodox, and Cordran, serving as primary or adjunctive therapies in this specialty area.
- Headquarters West Chester, United States
- Employees 100
- Stage Acquired
- SectorsHealthcare
- Website aquapharm.com
- Social LinkedIn
- Acquired by Almirall (Dec 2013)
- Legal Name Aqua Pharmaceuticals, Llc
Funding Insights of Aqua Pharm
Aqua Pharm has successfully raised a total of $53.67M through 1 strategic funding round. The most recent funding activity was a Series C round of $53.67 million completed in June 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $53.67M
- Total Rounds 1
- Last Round Series C — $53.67M
- First Round $53.67M
(Jun 2010)
- Investors Count 1
All 1 funding rounds of Aqua Pharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2010 | $53.67M | Series C | – | – |
2 investors in total: 2 institutional.
Investors in Aqua Pharm
Aqua Pharm has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Almirall and RoundTable Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare companies are built and supported through strategic investments. | roundtablehp.com | Lake Forest, United States | ||
Generic finished formulations are manufactured and commercialized by Almirall. | 1943 | almirall.com | Barcelona, Spain |
Investor details for Aqua Pharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aqua Pharm
1 people are tracked at Aqua Pharm (1 in leadership); the tracked headcount is 100.
| Name | Role | Group |
|---|---|---|
Ron Menezes | President & CEO | Leadership |
Complete people profiles for Aqua Pharm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Aqua Pharm
3 dated milestones of Aqua Pharm across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Aqua Pharm is founded.
- Funding First funding round of $53.7M.
- Exit Acquired by Almirall.
Competitors of Aqua Pharm
Aqua Pharm has 3 listed competitors in our database, 3 of them funded. They include Revance Therapeutics, Dermavant and Sol-Gel Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| revance.com | 2002 | Newark, United States | $154.56M | 597 | Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | |
| dermavant.com | 2016 | Phoenix, United States | $160M | Small molecule therapeutics for inflammatory skin diseases are developed. | ||
| sol-gel.com | 1998 | United States | $9M | Developing topical drug products for the treatment of rosacea, acne and interdigital tinea pedis. |
Detailed competitors of Aqua Pharm
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aqua Pharm
Websites that share an audience with Aqua Pharm (aquapharm.com).
Websites whose visitors overlap most with Aqua Pharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
activatethecard.com | activatethecard.com | 100% | – | ||
| acellapharma.com | 59% | 4K | #5,202,055 | View details | |
| deciphera.com | 58% | 12.2K | #2,044,202 | View details | |
euphoricpharma.com | euphoricpharma.com | 58% | – | ||
| taurx.com | 58% | 8.1K | #2,623,902 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Aqua Pharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Dermatology
3 companies that operate in the same segment as Aqua Pharm (Dermatology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aqua Pharm
Aqua Pharm was founded in 2004 and raised its 1st funding round 6 years after it was founded.
Aqua Pharm is headquartered in West Chester, United States. It is registered at West Chester, Pennsylvania, United States.
Ron Menezes is the CEO of Aqua Pharm, as recorded in our data.
Aqua Pharm is a funded company, having raised a total of $53.67M across 1 funding round to date. The company's 1st funding round was a Series C of $53.67M, raised on Jun 2010.
Aqua Pharm has 100 employees.
Founded in 2004, Aqua Pharm operates from West Chester, United States, as a provider in the pharmaceutical sector focused on dermatological treatments. Drugs are marketed for conditions including impetigo, acne vulgaris, actinic keratoses, seborrheic dermatitis, atopic dermatitis, and corticosteroid-responsive dermatoses. Key products encompass Altabax, Veltin, Acticlate, Fluoroplex, Xologel, Verdeso, Monodox, and Cordran, serving as primary or adjunctive therapies in this specialty area.
Aqua Pharm's top competitors include Revance Therapeutics, Dermavant and Sol-Gel Technologies.
Aqua Pharm has 2 investors. Key investors include Almirall, and RoundTable Healthcare Partners.
Aqua Pharm operates through Aqua Pharmaceuticals, Llc.
Yes. Aqua Pharm was acquired by Almirall in December 2013.